Since the introduction of simultaneous radiochemotherapy with temozolomide, an up to 21.5% increased number of patients is seen with tumor recurrence, with a positive correlation to supraventricular tumor location and methylated MGMT status [10,11]. The gene discussed is MGMT; the disease is neoplasm.